These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32768411)

  • 1. Iminosugars: A host-targeted approach to combat Flaviviridae infections.
    Evans DeWald L; Starr C; Butters T; Treston A; Warfield KL
    Antiviral Res; 2020 Dec; 184():104881. PubMed ID: 32768411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iminosugar antivirals: the therapeutic sweet spot.
    Alonzi DS; Scott KA; Dwek RA; Zitzmann N
    Biochem Soc Trans; 2017 Apr; 45(2):571-582. PubMed ID: 28408497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.
    Karade SS; Hill ML; Kiappes JL; Manne R; Aakula B; Zitzmann N; Warfield KL; Treston AM; Mariuzza RA
    J Med Chem; 2021 Dec; 64(24):18010-18024. PubMed ID: 34870992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.
    Zhao X; Guo F; Comunale MA; Mehta A; Sehgal M; Jain P; Cuconati A; Lin H; Block TM; Chang J; Guo JT
    Antimicrob Agents Chemother; 2015 Jan; 59(1):206-16. PubMed ID: 25348530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.
    Miller JL; Tyrrell BE; Zitzmann N
    Adv Exp Med Biol; 2018; 1062():277-301. PubMed ID: 29845540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iminosugars: Promising therapeutics for influenza infection.
    Tyrrell BE; Sayce AC; Warfield KL; Miller JL; Zitzmann N
    Crit Rev Microbiol; 2017 Sep; 43(5):521-545. PubMed ID: 27931136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue).
    Warfield KL; Plummer E; Alonzi DS; Wolfe GW; Sampath A; Nguyen T; Butters TD; Enterlein SG; Stavale EJ; Shresta S; Ramstedt U
    Viruses; 2015 May; 7(5):2404-27. PubMed ID: 25984714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Small-Compound Inhibitor K22 Displays Broad Antiviral Activity against Different Members of the Family Flaviviridae and Offers Potential as a Panviral Inhibitor.
    García-Nicolás O; V'kovski P; Vielle NJ; Ebert N; Züst R; Portmann J; Stalder H; Gaschen V; Vieyres G; Stoffel M; Schweizer M; Summerfield A; Engler O; Pietschmann T; Todt D; Alves MP; Thiel V; Pfaender S
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses.
    Chang J; Warren TK; Zhao X; Gill T; Guo F; Wang L; Comunale MA; Du Y; Alonzi DS; Yu W; Ye H; Liu F; Guo JT; Mehta A; Cuconati A; Butters TD; Bavari S; Xu X; Block TM
    Antiviral Res; 2013 Jun; 98(3):432-40. PubMed ID: 23578725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus.
    Miller JL; Hill ML; Brun J; Pountain A; Sayce AC; Zitzmann N
    Antiviral Res; 2019 Oct; 170():104551. PubMed ID: 31306674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs.
    Block TM; Jordan R
    Antivir Chem Chemother; 2001 Nov; 12(6):317-25. PubMed ID: 12018676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel imino sugar α-glucosidase inhibitors as antiviral compounds.
    Howe JD; Smith N; Lee MJ; Ardes-Guisot N; Vauzeilles B; Désiré J; Baron A; Blériot Y; Sollogoub M; Alonzi DS; Butters TD
    Bioorg Med Chem; 2013 Aug; 21(16):4831-8. PubMed ID: 23582447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyhydroxylated Quinolizidine Iminosugars as Nanomolar Selective Inhibitors of α-Glucosidases.
    Vieira Da Cruz A; Kanazawa A; Poisson JF; Behr JB; Py S
    J Org Chem; 2017 Sep; 82(18):9866-9872. PubMed ID: 28752763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses.
    Chang J; Wang L; Ma D; Qu X; Guo H; Xu X; Mason PM; Bourne N; Moriarty R; Gu B; Guo JT; Block TM
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1501-8. PubMed ID: 19223639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approaches in antiviral drug discovery against the Flaviviridae family.
    Baharuddin A; Hassan AA; Sheng GC; Nasir SB; Othman S; Yusof R; Othman R; Rahman NA
    Curr Pharm Des; 2014; 20(21):3428-44. PubMed ID: 24001228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the selectivity of ER α-glucosidase inhibitors.
    O'Keefe S; Roebuck QP; Nakagome I; Hirono S; Kato A; Nash R; High S
    Glycobiology; 2019 Jul; 29(7):530-542. PubMed ID: 30976784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target.
    Sobala ŁF; Fernandes PZ; Hakki Z; Thompson AJ; Howe JD; Hill M; Zitzmann N; Davies S; Stamataki Z; Butters TD; Alonzi DS; Williams SJ; Davies GJ
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29595-29601. PubMed ID: 33154157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.
    Chapel C; Garcia C; Bartosch B; Roingeard P; Zitzmann N; Cosset FL; Dubuisson J; Dwek RA; Trépo C; Zoulim F; Durantel D
    J Gen Virol; 2007 Apr; 88(Pt 4):1133-1143. PubMed ID: 17374756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.